SCHEMBL2492243

SCHEMBL2492243

CN(CCO)c1ccc(-c2ccccc2)c(-c2ccccc2)c1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.40
MEN1 O00255 6/20 0.38
KMT2A Q03164 6/20 0.38
ALDH1A1 P00352 6/20 0.38
USP2 O75604 3/20 0.38
MAPT P10636 2/20 0.38
CASP1 P29466 2/20 0.38
CASP7 P55210 2/20 0.38
HBB P68871 2/20 0.38
HSD17B10 Q99714 2/20 0.38
GAA P10253 1/20 0.38
CRHBP P24387 1/20 0.38
BRCA1 P38398 1/20 0.38
CRHR2 Q13324 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 3/20 0.34
TP53 P04637 1/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34
KEAP1 Q14145 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2491890 0.91 MEN1 (0.33) CHEK1MEN1KMT2AALDH1A1USP2
SCHEMBL2495688 0.83 ALDH1A1 (0.41) CHEK1MEN1KMT2AALDH1A1USP2
SCHEMBL2490777 0.79 PDE4B (0.42) CHEK1MEN1KMT2AALDH1A1USP2
SCHEMBL2495630 0.75 PDCD1 (0.35) CHEK1MEN1KMT2AALDH1A1USP2
SCHEMBL15856452 0.74 PTGS2 (0.34) MEN1KMT2AMAPTHPGD
SCHEMBL2492135 0.72 MEN1 (0.43) CHEK1MEN1KMT2AALDH1A1USP2
SCHEMBL15856493 0.72 PTGS2 (0.36) MEN1KMT2AALDH1A1USP2KDM4E
SCHEMBL15856545 0.72 PTGS2 (0.36) MEN1KMT2AALDH1A1USP2KDM4E
SCHEMBL2492863 0.71 PDE4B (0.40) CHEK1MEN1KMT2AALDH1A1USP2
SCHEMBL28901480 0.71 BACE1 (0.48) ALDH1A1HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH CHEK1 2888/4885MEN1 1585/4885KMT2A 2108/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 CHEK1 2673/4885MEN1 1346/4885KMT2A 2219/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R CHEK1 2491/4885MEN1 1200/4885KMT2A 2287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.